<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="COVID-19 Adverse Outcome Pathway" Version="20200407" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">Experimental pathway to investigate overlap of Covid-19 downstream effects and adverse outcome pathways related to lung injury.</Comment>
  <Comment Source="WikiPathways-description">Experimenting with links in line with bioinformatics analysis of COVID-19 genes and AOP knowledge. Work in progress!</Comment>
  <Graphics BoardWidth="1342.4665650000002" BoardHeight="892.0"/>
  <DataNode TextLabel="TNF" Type="GeneProduct" GroupRef="c757c">
    <Graphics CenterX="1053.5036195944926" CenterY="628.3747952950098" Width="80.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Entrez Gene" ID="7124"/>
  </DataNode>
  <DataNode TextLabel="IL10" Type="GeneProduct" GroupRef="c757c">
    <Graphics CenterX="1051.4665650000006" CenterY="598.2762815625" Width="80.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Entrez Gene" ID="3586"/>
  </DataNode>
  <DataNode TextLabel="IL1B" Type="GeneProduct" GroupRef="c757c">
    <Graphics CenterX="1048.5503247183947" CenterY="481.9051923136259" Width="80.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Entrez Gene" ID="3553"/>
  </DataNode>
  <DataNode TextLabel="IL7" Type="GeneProduct" GroupRef="c757c">
    <Graphics CenterX="1049.4665650000006" CenterY="509.9634346085064" Width="80.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Entrez Gene" ID="3574"/>
  </DataNode>
  <DataNode TextLabel="CSF3" Type="GeneProduct" GroupRef="c757c">
    <Graphics CenterX="1050.4728900254827" CenterY="569.5814732894403" Width="80.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Entrez Gene" ID="1440"/>
  </DataNode>
  <DataNode TextLabel="SARS-CoV-2 and Angiotensin-converting&#10;enzyme 2 (ACE2) receptor:&#10;Molecular mechanisms and&#10;potential therapeutic target&#10;(Homo sapiens)" GraphId="ac2f7" Type="Pathway" GroupRef="a3e09">
    <Graphics CenterX="384.16075031250006" CenterY="438.15271671875" Width="288.439633125" Height="75.80061218750006" ZOrder="32768" FontWeight="Bold" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="14961e"/>
    <Xref Database="WikiPathways" ID="WP4883"/>
  </DataNode>
  <DataNode TextLabel="LTF danger signal&#10;response pathway" GraphId="ace80" Type="Pathway" GroupRef="c757c">
    <Graphics CenterX="675.4665650000002" CenterY="570.2762815625" Width="106.0" Height="25.0" ZOrder="32768" FontWeight="Bold" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="14961e"/>
    <Xref Database="WikiPathways" ID="WP4478"/>
  </DataNode>
  <DataNode TextLabel="AGT" GraphId="b6003" Type="GeneProduct" GroupRef="a3e09">
    <Graphics CenterX="456.45596855932365" CenterY="545.5480604375146" Width="80.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Entrez Gene" ID="183"/>
  </DataNode>
  <DataNode TextLabel="SARS-CoV-2 and&#10;COVID-19 Pathway" GraphId="be0b0" Type="Pathway" GroupRef="a3e09">
    <Graphics CenterX="326.8585644227918" CenterY="514.3415487182835" Width="136.82116728183377" Height="57.69769256580463" ZOrder="32768" FontWeight="Bold" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="14961e"/>
    <Xref Database="WikiPathways" ID="WP4846"/>
  </DataNode>
  <DataNode TextLabel="positive regulation of&#10;leukocyte activation" GraphId="c6c98" GroupRef="c757c" Type="Pathway">
    <Graphics CenterX="1225.4665649999984" CenterY="506.2762815625" Width="136.0" Height="25.0" ZOrder="32768" FontWeight="Bold" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="14961e"/>
    <Xref Database="Other" ID="GO:0002696"/>
  </DataNode>
  <DataNode TextLabel="Toll-like&#10;receptor signaling" GraphId="cd4a3" Type="Pathway" GroupRef="c757c">
    <Graphics CenterX="737.0738435555446" CenterY="485.0243405905386" Width="117.75526975989933" Height="39.58508991996632" ZOrder="32768" FontWeight="Bold" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="14961e"/>
    <Xref Database="WikiPathways" ID="WP75"/>
  </DataNode>
  <DataNode TextLabel="IL8" GraphId="cf7c5" Type="GeneProduct" GroupRef="c757c">
    <Graphics CenterX="674.1165547907224" CenterY="605.6281784133429" Width="80.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Entrez Gene" ID="3576"/>
  </DataNode>
  <DataNode TextLabel="Lung fibrosis" GraphId="d20e7" Type="Pathway" GroupRef="c757c">
    <Graphics CenterX="967.4665650000005" CenterY="353.2762815625" Width="90.0" Height="25.0" ZOrder="32768" FontWeight="Bold" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="14961e"/>
    <Xref Database="WikiPathways" ID="WP3624"/>
  </DataNode>
  <DataNode TextLabel="IL2" GraphId="d380c" Type="GeneProduct" GroupRef="c757c">
    <Graphics CenterX="1051.1050176197464" CenterY="539.7650769419166" Width="80.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Entrez Gene" ID="3558"/>
  </DataNode>
  <DataNode TextLabel="CCL3" GraphId="eb71b" Type="GeneProduct" GroupRef="c757c">
    <Graphics CenterX="815.1165547907226" CenterY="527.2020637127242" Width="80.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Entrez Gene" ID="6348"/>
  </DataNode>
  <DataNode TextLabel="TMPRSS2" GraphId="eba5c" Type="GeneProduct" GroupRef="a3e09">
    <Graphics CenterX="322.0413910296837" CenterY="572.6305986151294" Width="80.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Entrez Gene" ID="7113"/>
  </DataNode>
  <DataNode TextLabel="CCL2" GraphId="ee6e7" Type="GeneProduct" GroupRef="c757c">
    <Graphics CenterX="1225.1165547907215" CenterY="566.2564240636835" Width="80.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Entrez Gene" ID="6347"/>
  </DataNode>
  <DataNode TextLabel="ACE2" GraphId="f33e8" Type="GeneProduct" GroupRef="a3e09">
    <Graphics CenterX="322.0413910296836" CenterY="544.3644567850395" Width="80.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Entrez Gene" ID="59272"/>
  </DataNode>
  <DataNode TextLabel="IL6" GraphId="f425c" Type="GeneProduct" GroupRef="c757c">
    <Graphics CenterX="1052.4261849015807" CenterY="655.1604620735245" Width="80.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Entrez Gene" ID="3569"/>
  </DataNode>
  <DataNode TextLabel="IL2RA" GraphId="f59b7" Type="GeneProduct" GroupRef="c757c">
    <Graphics CenterX="1223.105017619743" CenterY="539.5923453596321" Width="80.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Entrez Gene" ID="3559"/>
  </DataNode>
  <DataNode TextLabel="Cytokines and&#10;inflammatory&#10;response" GraphId="f9a57" Type="Pathway" GroupRef="c757c">
    <Graphics CenterX="1048.4665650000006" CenterY="436.5262815625" Width="150.0" Height="48.5" ZOrder="32768" FontWeight="Bold" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="14961e"/>
    <Xref Database="WikiPathways" ID="WP530"/>
  </DataNode>
  <DataNode TextLabel="CXCL10" GraphId="feac7" Type="GeneProduct" GroupRef="c757c">
    <Graphics CenterX="814.4665650000005" CenterY="557.1144220504074" Width="80.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Entrez Gene" ID="3627"/>
  </DataNode>
  <Interaction GroupRef="a3e09">
    <Comment>Proteolytic processing</Comment>
    <BiopaxRef>f09</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="362.0413910296836" Y="544.3644567850395" GraphRef="f33e8" RelX="1.0" RelY="0.0"/>
      <Point X="416.45596855932365" Y="545.5480604375146" GraphRef="b6003" RelX="-1.0" RelY="0.0" ArrowHead="mim-modification"/>
    </Graphics>
    <Xref Database="BioGrid" ID="882484"/>
  </Interaction>
  <Interaction GraphId="id6de06d86" GroupRef="c757c">
    <Comment>GeneMANIA predicted interaction</Comment>
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineStyle="Broken" LineThickness="1.0">
      <Point X="714.1165547907224" Y="605.6281784133429" GraphRef="cf7c5" RelX="1.0" RelY="0.0"/>
      <Point X="748.4665650000005" Y="566.4151210630336"/>
      <Point X="775.1165547907226" Y="527.2020637127242" GraphRef="eb71b" RelX="-1.0" RelY="0.0"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id981d12bb" GroupRef="c757c">
    <Comment>GeneMANIA predicted interaction</Comment>
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineStyle="Broken" LineThickness="1.0">
      <Point X="1092.4261849015807" Y="655.1604620735245" GraphRef="f425c" RelX="1.0" RelY="0.0"/>
      <Point X="1137.4665649999984" Y="610.7084430686041"/>
      <Point X="1185.1165547907215" Y="566.2564240636835" GraphRef="ee6e7" RelX="-1.0" RelY="0.0"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idf55cb6e4" GroupRef="c757c">
    <Comment>GeneMANIA predicted interaction</Comment>
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineStyle="Broken" LineThickness="1.0">
      <Point X="1012.4261849015807" Y="655.1604620735245" GraphRef="f425c" RelX="-1.0" RelY="0.0"/>
      <Point X="934.4665650000005" Y="630.3943202434336"/>
      <Point X="714.1165547907224" Y="605.6281784133429" GraphRef="cf7c5" RelX="1.0" RelY="0.0"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idfc67b63" GroupRef="c757c">
    <Comment>GeneMANIA predicted interaction</Comment>
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineStyle="Broken" LineThickness="1.0">
      <Point X="714.1165547907224" Y="605.6281784133429" GraphRef="cf7c5" RelX="1.0" RelY="0.0"/>
      <Point X="748.4665650000005" Y="581.3713002318751"/>
      <Point X="774.4665650000005" Y="557.1144220504074" GraphRef="feac7" RelX="-1.0" RelY="0.0"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idfe2de42e" GroupRef="c757c">
    <Comment>GeneMANIA identified physical interaction</Comment>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1091.1050176197464" Y="539.7650769419166" GraphRef="d380c" RelX="1.0" RelY="0.0"/>
      <Point X="1183.105017619743" Y="539.5923453596321" GraphRef="f59b7" RelX="-1.0" RelY="0.0"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Label TextLabel="AO (KE:1751) - Increased mortality" GraphId="a32e5" GroupRef="c404e">
    <Graphics CenterX="948.5" CenterY="259.0" Width="213.0" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="MIE (KE:1739) - Binding of S protein to ACE receptor" GraphId="a5023" GroupRef="c404e">
    <Graphics CenterX="995.0" CenterY="161.0" Width="312.0" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="Events related to the Adverse Outcome Pathway for&#10;Acute respiratory distress associated mortality (AOP:320)" GraphId="b40a2" GroupRef="c404e">
    <Graphics CenterX="1068.5" CenterY="114.75" Width="463.0" Height="88.5" ZOrder="28672" FillColor="ffffff" FontWeight="Bold" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="15 genes included in the pathway:&#10;genes with direct evidence of association&#10;to COVID-19 in the Comparative Toxicogenomics Database&#10;(http://ctdbase.org/)" GraphId="b8650">
    <Comment>As of 8th April, 2020</Comment>
    <Graphics CenterX="663.5" CenterY="823.5" Width="351.0" Height="77.0" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="KE4 (KE:1748) -  &#9;Increase, the risk of acute respiratory failure" GraphId="bc4ba" GroupRef="c404e">
    <Graphics CenterX="1018.0" CenterY="239.0" Width="344.0" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="KE1 (KE:1738) - Enhanced viral entry and gene expression" GraphId="be031" GroupRef="c404e">
    <Graphics CenterX="1013.5" CenterY="180.0" Width="337.0" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="KE2 (KE:1496) - Increased, secretion of proinflammatory and profibrotic mediators" GraphId="d40df" GroupRef="c404e">
    <Comment>KE:1496 is also part of AOP:173 for lung fibrosis</Comment>
    <BiopaxRef>c88</BiopaxRef>
    <BiopaxRef>bab</BiopaxRef>
    <Graphics CenterX="1073.0" CenterY="199.0" Width="458.0" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="MIE" GraphId="e8044" GroupRef="a3e09">
    <Comment>MIE in AOP:320 and AOP:319</Comment>
    <Graphics CenterX="319.9588528520687" CenterY="596.5749080626007" Width="90.0" Height="25.0" ZOrder="28672" FillColor="ffffff" FontWeight="Bold" FontSize="14" Valign="Middle"/>
  </Label>
  <Label TextLabel="Legend" GraphId="e98ed" GroupRef="c404e">
    <Graphics CenterX="883.0" CenterY="80.0" Width="90.0" Height="25.0" ZOrder="28672" FillColor="ffffff" FontWeight="Bold" FontSize="14" Valign="Middle"/>
  </Label>
  <Label TextLabel="KE3 (KE:1750) - Increase inflammatory immune responses" GraphId="f4516" GroupRef="c404e">
    <Graphics CenterX="1010.0" CenterY="219.0" Width="340.0" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="KE2" GraphId="bb627" GroupRef="c757c">
    <Comment/>
    <Graphics CenterX="1050.8120281645693" CenterY="683.6409371251007" Width="90.0" Height="25.0" ZOrder="32771" FillColor="ffffff" FontWeight="Bold" FontSize="14" Valign="Middle"/>
  </Label>
  <Label TextLabel="KE1" GraphId="b61bc" GroupRef="c757c">
    <Comment/>
    <Graphics CenterX="770.8120281645689" CenterY="625.6409371251007" Width="90.0" Height="25.0" ZOrder="32772" FillColor="ffffff" FontWeight="Bold" FontSize="14" Valign="Middle"/>
  </Label>
  <Label TextLabel="KE3" GraphId="f446c" GroupRef="c757c">
    <Comment/>
    <Graphics CenterX="1220.8120281645663" CenterY="588.6409371251007" Width="90.0" Height="25.0" ZOrder="32773" FillColor="ffffff" FontWeight="Bold" FontSize="14" Valign="Middle"/>
  </Label>
  <Shape GraphId="a11c4" GroupRef="a3e09">
    <Graphics CenterX="326.1552695466977" CenterY="545.8002796294729" Width="130.60139802525367" Height="116.80197488380242" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="abe7a" GroupRef="c757c">
    <Comment>Pathways and KEs associated with lung fibrosis (AOP:173)</Comment>
    <BiopaxRef>bab</BiopaxRef>
    <Graphics CenterX="951.9665650000001" CenterY="524.2762815625" Width="705.0" Height="380.0" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="da506" GroupRef="c757c">
    <Comment>KE2 (KE:1496) is also part of the lung fibrosis pathway (WP3624) and AOP (AOP:173)</Comment>
    <BiopaxRef>bab</BiopaxRef>
    <Graphics CenterX="1049.9665650000006" CenterY="547.5262815625" Width="109.0" Height="301.5" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="de707" GroupRef="a3e09">
    <Graphics CenterX="384.5488910937501" CenterY="509.6244842187501" Width="310.6364196874998" Height="234.05952593749987" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="e69d3" GroupRef="c757c">
    <Graphics CenterX="1225.2165649999984" CenterY="541.5262815625" Width="130.5" Height="115.5" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="e7d95" GroupRef="c757c">
    <Graphics CenterX="675.4665650000002" CenterY="586.5262815625" Width="110.0" Height="71.5" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="d2977" GroupRef="c757c">
    <Comment>Associated with the MIE in Lung fibrosis AOP:173</Comment>
    <BiopaxRef>bab</BiopaxRef>
    <Graphics CenterX="739.4665650000002" CenterY="549.620801406286" Width="252.0" Height="175.31096031242805" ZOrder="32769" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="c3cff" GroupRef="c404e">
    <Comment>Associated with the MIE in Lung fibrosis AOP:173</Comment>
    <Graphics CenterX="1078.5118153909734" CenterY="172.34451984378597" Width="466.97636921805315" Height="215.31096031242805" ZOrder="32770" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Rotation="0.0"/>
  </Shape>
  <Group GroupId="c404e" Style="Group"/>
  <Group GroupId="c757c" Style="Group"/>
  <Group GroupId="a3e09" Style="Group"/>
  <InfoBox CenterX="0.0" CenterY="0.0"/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bab">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">29149350</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A Data Fusion Pipeline for Generating and Enriching Adverse Outcome Pathway Descriptions.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Toxicol Sci</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2018</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nymark P</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rieswijk L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ehrhart F</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Jeliazkova N</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tsiliki G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sarimveis H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Evelo CT</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hongisto V</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kohonen P</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Willighagen E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Grafström RC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c88">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">26979667</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nano-risk Science: application of toxicogenomics in an adverse outcome pathway framework for risk assessment of multi-walled carbon nanotubes.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Part Fibre Toxicol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Labib S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Williams A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yauk CL</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nikota JK</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wallin H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Vogel U</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Halappanavar S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">signaling pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000003</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">viral infectious disease</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">DOID:934</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">respiratory system disease pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001308</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">severe acute respiratory syndrome</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">DOID:2945</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f09">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10969042</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Circ Res</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2000</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Donoghue M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hsieh F</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Baronas E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Godbout K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gosselin M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Stagliano N</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Donovan M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Woolf B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Robison K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Jeyaseelan R</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Breitbart RE</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Acton S</bp:AUTHORS>
    </bp:PublicationXref>
  </Biopax>
</Pathway>